Abstract
The relative potencies of analogues of tryptamine and 5-hydroxytryptamine have been determined on the rat fundus preparation. This tissue had an amine oxidase activity, which, in the homogenate, was able to inactivate both tryptamine and 5-hydroxytryptamine to about the same degree. Amine oxidase inhibitors potentiated the action of tryptamine and many analogues on the isolated rat fundus preparation, but not the action of 5-hydroxytryptamine or of other hydroxytryptamines. This suggested that, in the isolated organ, the amine oxidase was unable to inactivate 5-hydroxytryptamine, but could inactivate tryptamine, 5-methoxytryptamine and many others. These results may be explained if it is supposed that tryptamine entered the cell, but because of the polar hydroxyl group 5-hydroxytryptamine did not. This hypothesis is supported by the oil/water partition coefficients. The structure/activity of the various tryptamine derivatives is discussed in the light of this assumption.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- AXELROD J., SENOH S., WITKOP B. O-Methylation of catechol amines in vivo. J Biol Chem. 1958 Sep;233(3):697–701. [PubMed] [Google Scholar]
- AXELROD J., TOMCHICK R. Enzymatic O-methylation of epinephrine and other catechols. J Biol Chem. 1958 Sep;233(3):702–705. [PubMed] [Google Scholar]
- BARLOW R. B., BLASCHKO H., HIMMS J. M., TRENDELENBURG U. Observations on omega-amino-polymethylene trimethylammonium compounds. Br J Pharmacol Chemother. 1955 Mar;10(1):116–123. doi: 10.1111/j.1476-5381.1955.tb00069.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- BLASCHKO H. Amine oxidase and amine metabolism. Pharmacol Rev. 1952 Dec;4(4):415–458. [PubMed] [Google Scholar]
- BRODIE B. B., HOGBEN C. A. Some physico-chemical factors in drug action. J Pharm Pharmacol. 1957 Jun;9(6):345–380. doi: 10.1111/j.2042-7158.1957.tb12289.x. [DOI] [PubMed] [Google Scholar]
- BROWN G. L., GILLESPIE J. S. The output of sympathetic transmitter from the spleen of the cat. J Physiol. 1957 Aug 29;138(1):81–102. doi: 10.1113/jphysiol.1957.sp005839. [DOI] [PMC free article] [PubMed] [Google Scholar]
- BURN J. H., RAND M. J. Effect of reserpine vasoconstriction caused by sympathomimetic amines. Lancet. 1958 Mar 29;1(7022):673–673. doi: 10.1016/s0140-6736(58)91090-0. [DOI] [PubMed] [Google Scholar]
- CORNE S. J., GRAHAM J. D. The effect of inhibition of amine oxidase in vivo on administered adrenaline, noradrenaline, tyramine and serotonin. J Physiol. 1957 Feb 15;135(2):339–349. doi: 10.1113/jphysiol.1957.sp005714. [DOI] [PMC free article] [PubMed] [Google Scholar]
- FREYBURGER W. A., GRAHAM B. E., RAPPORT M. M., SEAY P. H., GOVIER W. M., SWOAP O. F., VANDER BROOK M. J. The pharmacology of 5-hydroxytryptamine (serotonin). J Pharmacol Exp Ther. 1952 May;105(1):80–86. [PubMed] [Google Scholar]
- GILLESPIE L., Jr, EVARTS E. V., FLEMING T. C., SJOERDSMA A. [Relative lack of pharmacologic action of 3-methoxy analogue of norepinephrine]. Proc Soc Exp Biol Med. 1958 May;98(1):74–76. doi: 10.3181/00379727-98-23945. [DOI] [PubMed] [Google Scholar]
- HORITA A. beta-Phenylisopropylhydrazine, a potent and long acting monoamine oxidase inhibitor. J Pharmacol Exp Ther. 1958 Feb;122(2):176–181. [PubMed] [Google Scholar]
- KOSTERLITZ H. W., KRAYER O., MATALLANA A. Studies on veratrum alkaloids, XXII. Periodic activity of the sino-auricular node of the denervated cat heart caused by veratramine. J Pharmacol Exp Ther. 1955 Apr;113(4):460–469. [PubMed] [Google Scholar]
- PATON W. D. A pendulum auxotonic lever. J Physiol. 1957 Jul 11;137(2):35P–356. [PubMed] [Google Scholar]
- QUADBECK G., ROHM E. Uber substituierte Gramine als wirksame Serotonin-Antagonisten. Hoppe Seylers Z Physiol Chem. 1954;297(3-6):229–237. [PubMed] [Google Scholar]